pubmed-article:1355564 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0038411 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0031350 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0162643 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C0035268 | lld:lifeskim |
pubmed-article:1355564 | lifeskim:mentions | umls-concept:C1749889 | lld:lifeskim |
pubmed-article:1355564 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1355564 | pubmed:dateCreated | 1992-10-6 | lld:pubmed |
pubmed-article:1355564 | pubmed:abstractText | In the evaluation of treatment failure in Streptococcus pyogenes pharyngitis it is necessary to distinguish between persistence of the original streptococcus and acquisition of a new strain. We used the analysis of restriction fragment length polymorphism (RFLP) of total DNA and of ribosomal DNA (rDNA) regions (ribotypes) as epidemiological tools to compare 43 pre- and post-treatment S. pyogenes strains obtained from 20 patients. In 16 cases pre- and post-treatment strains gave indistinguishable RFLP patterns of total DNA, strongly suggesting relapse with the same strain. However, in four cases different patterns were obtained for the pre- and post-treatment isolates, indicating recurrence due to the acquisition of a new strain. Ribotyping did not improve discrimination among strains. Thus, analysis of DNA RFLP is a promising method for distinguishing recurrence from relapse in failures of pharyngitis treatment. | lld:pubmed |
pubmed-article:1355564 | pubmed:language | eng | lld:pubmed |
pubmed-article:1355564 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1355564 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1355564 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1355564 | pubmed:month | Sep | lld:pubmed |
pubmed-article:1355564 | pubmed:issn | 0022-2615 | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:ElionJJ | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:Lambert-Zecho... | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:BingenEE | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:DenamurEE | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:el LakanyMM | lld:pubmed |
pubmed-article:1355564 | pubmed:author | pubmed-author:BraimiNN | lld:pubmed |
pubmed-article:1355564 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1355564 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:1355564 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1355564 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1355564 | pubmed:pagination | 162-4 | lld:pubmed |
pubmed-article:1355564 | pubmed:dateRevised | 2008-8-19 | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:meshHeading | pubmed-meshheading:1355564-... | lld:pubmed |
pubmed-article:1355564 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1355564 | pubmed:articleTitle | DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis. | lld:pubmed |
pubmed-article:1355564 | pubmed:affiliation | Laboratoire de Bactériologie, Hôpital Robert Debré, Paris, France. | lld:pubmed |
pubmed-article:1355564 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1355564 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1355564 | lld:pubmed |